刺激药物缩短了损害情绪爆发的持续时间

相关实验视频

Updated: May 21, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.5K

Lauren M Spring¹, Joseph E Schwartz¹, Gabrielle A Carlson¹

¹Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.

JAACAP open

|March 20, 2025

概括

延长释放 (ER) 兴奋剂药物显著减少了注意力缺陷/多动症 (ADHD) 儿童情绪爆发的持续时间. 立即释放 (IR) 兴奋剂没有显示这种效果,突出了ER兴奋剂作为ADHD情绪失调的潜在治疗方法.

科学领域:

儿童和青少年精神病学儿童和青少年精神病学
神经发育障碍神经发育障碍
药理学药理学是指药理学的学科.

背景情况:

情绪失调是注意力缺陷/多动症障碍 (ADHD) 的一个显著障碍.
严重的情绪爆发是这种失调的常见表现.
了解药物对爆发持续时间的影响对于有效的ADHD管理至关重要.

研究的目的:

分析兴奋剂药物对ADHD儿童情绪爆发持续时间的影响.
为了比较延长释放 (ER) 与即时释放 (IR) 兴奋剂配方的效果.
调查影响暴发持续时间的因素,包括药物类型和剂量.

主要方法:

从精神病医院住院儿童 (5-12岁) 的数据进行二次分析.
在服用PRN药物后,使用行为活动评分表来追踪情绪爆发.
检查各种变量,包括兴奋剂类型 (ER/IR),剂量,同时服用的药物和一天中的时间.

主要成果:

在ER兴奋剂药物中发生的爆发时间显著更短 (大约2小时). 20分钟) 比没有兴奋剂的人要多.
与没有兴奋剂相比,在ER兴奋剂下,侵略性爆发的时间大约短30分钟.
立即释放 (IR) 和短效兴奋剂没有显示出爆发持续时间的显著减少.

结论:

延长释放 (ER) 兴奋剂药物与ADHD儿童的情绪爆发持续时间较短有关.
在这种人群中,ER刺激剂在控制严重情绪爆发方面可能比IR刺激剂更有效.
需要进一步研究优化ADHD情绪失调的兴奋剂疗法.

关键词:

动荡动荡是一种动荡.神经麻醉药是一种神经麻醉药.亲爱的亲爱的亲爱的刺激剂是一种刺激剂.气爆发的爆发是什么意思

相关概念视频

01:24

Mania and Antimanic Drugs: Overview

106

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...

106

01:23

Antidepressant Drugs: MAOIs and Other Agents

174

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

174

01:25

Adrenergic Agonists: Indirect-Acting Agents

1.4K

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

1.4K

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

201

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

201